NCT04077671View on ClinicalTrials.gov

CHF6467 SAD and MAD in Patients With Diabetic Foot Ulcer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

October 17, 2018

Primary Completion Date

January 7, 2021

Study Completion Date

January 7, 2021

Conditions
Diabetic Neuropathic Foot Ulcers
Interventions
BIOLOGICAL

CHF6467 active

CHF6467, is mutated form of the human Nerve Growth Factor (NGF).

Trial Locations (1)

1618

Comac Medical Ltd., Sofia

Sponsors

Collaborators (1)

Comac Medical
All Listed Sponsors
collaborator

Comac Medical

INDUSTRY

lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT04077671 - CHF6467 SAD and MAD in Patients With Diabetic Foot Ulcer | Biotech Hunter | Biotech Hunter